HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PBH
Prestige Consumer Healthcare Inc
Healthcare Drug Manufacturers - Specialty & Generic · New York, USA · Reports in usd
Market Cap: $2.83B
Market Cap
$2.83B
Enterprise Val
$3.85B
P/E Ratio
15.20
P/B Ratio
1.55
Trailing PEG (1Y)
-0.75
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q3 2026
Book Value$1.83B
Gross Margin55.52%
Profit Margin55.52%
Return on Equity10.16%
Return on Assets5.42%
Current Ratio3.11
Debt/Equity0.59
LT Debt/Equity0.59
Revenue Per Share5.89

Income Statement

Dec 31, 2025
Revenue$283.4M
Cost of Revenue$126.1M
Gross Profit$157.4M
R&D$0.00
SG&A$69.7M
Operating Expenses$74.9M
Operating Income$82.5M
Interest Expense$10.7M
Tax Expense$15.1M
Net Income$46.7M
EPS (Basic)$0.98
EPS (Diluted)$0.97
EBIT$72.5M
EBITDA$82.0M
Consolidated Income$46.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$62.4M
Accounts Receivable$190.5M
Inventory$163.6M
Current Assets$433.4M
LT Investments$0.00
Property, Plant & Equipment$174.7M
Intangibles$2.88B
Non-Current Assets$3.06B
Total Assets$3.49B
Accounts Payable$42.9M
Current Debt$8.6M
Current Liabilities$139.6M
LT Debt$1.07B
Non-Current Liabilities$1.53B
Total Liabilities$1.67B
Total Debt$1.08B
Retained Earnings$1.69B
Shareholder Equity$1.83B
Shares Outstanding48,084,010

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$78.3M
Investing Cash Flow-$128.6M
Financing Cash Flow-$6.7M
CapEx-$3.0M
Free Cash Flow$75.3M
Depreciation & Amort.$9.5M
Stock-Based Comp$2.7M
Acquisitions / Disposals-$125.5M
Investment Activity$0.00
Debt Issued/Repaid$39.4M
Equity Issued/Repaid-$45.8M
Dividends Paid$0.00
Net Change in Cash-$56.7M
Data cached · Meta live · Daily live · Statements live · TTL 24h